Bristol Myers Squibb
Pharmaceuticals
BMY
$ 72 (0.74)%
Share price
$ 154 bn
Market Cap
$ 185 bn
Enterprise Value
Carbon footprint
Primary Climate Goal
Bristol Myers Squibb aims to achieve net zero for Scope 1 + 2 by 2040
This target has not been verified as science based according to SBTi
GHG emissions and Carbon intensity
Bristol Myers Squibb reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 278 Kt (-6 /-2.1% y-o-y). Also positively, carbon intensity dropped to 6.5 t (-4.4 /-40.4% y-o-y).
Bristol Myers Squibb's Scope 3 emissions tumbled to 12 Kt (
The company is committed to achieving net zero for Scope 1 + 2 by 2040, which translates into the estimated reduction of -14 Kt per annum over the period of FY2021 - FY2040. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.
Copyright © 2023 Exerica. All rights reserved.